WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the third quarter of 2007 on Monday, November 12, 2007 after the close of the stock market, with an accompanying conference call on Tuesday, November 13, 2007 at 11:00 A.M. ET.
